Publications by authors named "C Paoletti"

Skin infections are currently a worldwide emergency as antibiotic-resistant bacteria are spreading, leading to the ineffectiveness of most antibiotics and antibacterial strategies. Consequently, there is an urgency of developing and testing innovative antibacterial therapies. As traditional 2D cell culture and planktonic bacteria culture can be obsolete due to their incapability of resembling the complex infection environment, 3D skin models can be a powerful tool to test and validate therapies.

View Article and Find Full Text PDF

An adult pet tawny owl () presented to a veterinary hospital at Parma University with a history of head trauma. After a critical care protocol including thermal, oxygen and fluid support aimed at stabilizing the patient, a neurological examination was performed. During neurological evaluation, marked lethargy and an inability to rise from a recumbent position was noted.

View Article and Find Full Text PDF

Cardiac fibrosis is one of the main causes of heart failure, significantly contributing to mortality. The discovery and development of effective therapies able to heal fibrotic pathological symptoms thus remain of paramount importance. Micro-physiological systems (MPS) are recently introduced as promising platforms able to accelerate this finding.

View Article and Find Full Text PDF

Objective: To characterize epidemiological, clinical, radiographic, and echocardiographic features of cardiac diseases in guinea pigs examined at a referral exotics center.

Animals: 80 guinea pigs.

Procedures: Medical records of guinea pigs that had echocardiography performed between June 2010 and January 2021 were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • Some breast cancer patients can take medicine for a long time, while others get worse quickly, and a blood test called Thymidine Kinase activity (TKa) can help predict how they will do!
  • New research shows that a low TKa score means a lower chance of getting worse within 30 or 60 days, and it also indicates that these patients live longer without their disease getting worse!
  • This new blood test, called DiviTumTKa, gives important information to help doctors decide if patients need more treatment or can stick with their current one!
View Article and Find Full Text PDF